Skip to main content

08.12.2024 | Original Paper

Thinning of central foveal thickness in the retina of patients with schizophrenia

verfasst von: Jiayi Zhu, Zijing Wang, Tianzhen Chen, Yun Zhou, Feikang Xu, Jiang Du, Min Zhao

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience

Einloggen, um Zugang zu erhalten

Abstract

The neural retina shares a common embryonic origin with the brain and yields pathological changes like that in the brain in various neuropsychiatric disorders, including schizophrenia. Non-invasive examination by optical coherence tomography (OCT) revealed retinal structure abnormalities in patients with schizophrenia. This study investigated retina structures in 29 patients with schizophrenia and 25 healthy controls in a Chinese Han ethnic population with spectral domain OCT. Measurements of central foveal thickness (CFT) as well as other retinal structures in macular and peripapillary subregions were performed. Associations between OCT parameters and clinical features, including severity of positive and negative symptoms, disease duration and antipsychotic dosage were analyzed. With controlling for age and sex, patients showed significantly thinner CFT, thinner central macular thickness, and thinner total retinal thickness in subregions of the central, inner superior, inner temporal, and inner nasal macula of both eyes, thinner ganglion cell complex in a subregion of the left eye, as well as larger cup volume in the peripapillary region of the right eye. In addition, CFT also negatively correlated with severity of negative symptoms. These findings suggest that CFT has the potential to be a disease biomarker of schizophrenia.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Brundtland GH (2001) From the World Health Organization. Mental health: new understanding, new hope. JAMA 286(19):2391PubMedCrossRef Brundtland GH (2001) From the World Health Organization. Mental health: new understanding, new hope. JAMA 286(19):2391PubMedCrossRef
3.
Zurück zum Zitat Nordgaard J, Revsbech R, Saebye D, Parnas J (2012) Assessing the diagnostic validity of a structured psychiatric interview in a first-admission hospital sample. World Psychiatry 11(3):181–185PubMedPubMedCentralCrossRef Nordgaard J, Revsbech R, Saebye D, Parnas J (2012) Assessing the diagnostic validity of a structured psychiatric interview in a first-admission hospital sample. World Psychiatry 11(3):181–185PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Abbasi J (2017) A retinal scan for alzheimer disease. JAMA 318(14):1314PubMed Abbasi J (2017) A retinal scan for alzheimer disease. JAMA 318(14):1314PubMed
5.
Zurück zum Zitat Huang SC, Pisa M, Guerrieri S, Dalla Costa G, Comi G, Leocani L (2024) Optical coherence tomography with voxel-based morphometry: a new tool to unveil focal retinal neurodegeneration in multiple sclerosis. Brain Commun 6(1):fcad249PubMedCrossRef Huang SC, Pisa M, Guerrieri S, Dalla Costa G, Comi G, Leocani L (2024) Optical coherence tomography with voxel-based morphometry: a new tool to unveil focal retinal neurodegeneration in multiple sclerosis. Brain Commun 6(1):fcad249PubMedCrossRef
8.
Zurück zum Zitat Carazo-Barrios L, Archidona-Arranz A, Claros-Ruiz A, Garcia-Basterra I, Garzon-Maldonado FJ, Serrano-Castro V, Gutierrez-Bedmar M, Barbancho MA, De la Cruz CC, Garcia-Campos JM et al (2021) Correlation between retinal nerve fibre layer thickness and white matter lesions in Alzheimer’s disease. Int J Geriatr Psychiatry 36(6):935–942PubMedCrossRef Carazo-Barrios L, Archidona-Arranz A, Claros-Ruiz A, Garcia-Basterra I, Garzon-Maldonado FJ, Serrano-Castro V, Gutierrez-Bedmar M, Barbancho MA, De la Cruz CC, Garcia-Campos JM et al (2021) Correlation between retinal nerve fibre layer thickness and white matter lesions in Alzheimer’s disease. Int J Geriatr Psychiatry 36(6):935–942PubMedCrossRef
9.
Zurück zum Zitat Eslami M, Lichtman-Mikol S, Razmjou S, Bernitsas E (2022) Optical coherence tomography in chronic relapsing inflammatory optic neuropathy, neuromyelitis optica and multiple sclerosis: a comparative study. Brain Sci 12(9):1140PubMedPubMedCentralCrossRef Eslami M, Lichtman-Mikol S, Razmjou S, Bernitsas E (2022) Optical coherence tomography in chronic relapsing inflammatory optic neuropathy, neuromyelitis optica and multiple sclerosis: a comparative study. Brain Sci 12(9):1140PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Lee WW, Tajunisah I, Sharmilla K, Peyman M, Subrayan V (2013) Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography. Invest Ophthalmol Vis Sci 54(12):7785–7792PubMedCrossRef Lee WW, Tajunisah I, Sharmilla K, Peyman M, Subrayan V (2013) Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography. Invest Ophthalmol Vis Sci 54(12):7785–7792PubMedCrossRef
11.
Zurück zum Zitat Sarkar S, Rajalakshmi AR, Avudaiappan S, Eswaran S (2021) Exploring the role of macular thickness as a potential early biomarker of neurodegeneration in acute schizophrenia. Int Ophthalmol 41(8):2737–2746PubMedCrossRef Sarkar S, Rajalakshmi AR, Avudaiappan S, Eswaran S (2021) Exploring the role of macular thickness as a potential early biomarker of neurodegeneration in acute schizophrenia. Int Ophthalmol 41(8):2737–2746PubMedCrossRef
12.
Zurück zum Zitat Celik M, Kalenderoglu A, Sevgi Karadag A, Bekir Egilmez O, Han-Almis B, Simsek A (2016) Decreases in ganglion cell layer and inner plexiform layer volumes correlate better with disease severity in schizophrenia patients than retinal nerve fiber layer thickness: findings from spectral optic coherence tomography. Eur Psychiatry 32:9–15PubMedCrossRef Celik M, Kalenderoglu A, Sevgi Karadag A, Bekir Egilmez O, Han-Almis B, Simsek A (2016) Decreases in ganglion cell layer and inner plexiform layer volumes correlate better with disease severity in schizophrenia patients than retinal nerve fiber layer thickness: findings from spectral optic coherence tomography. Eur Psychiatry 32:9–15PubMedCrossRef
13.
Zurück zum Zitat Oddone F, Lucenteforte E, Michelessi M, Rizzo S, Donati S, Parravano M, Virgili G (2016) Macular versus retinal nerve fiber layer parameters for diagnosing manifest glaucoma: a systematic review of diagnostic accuracy studies. Ophthalmology 123(5):939–949PubMedCrossRef Oddone F, Lucenteforte E, Michelessi M, Rizzo S, Donati S, Parravano M, Virgili G (2016) Macular versus retinal nerve fiber layer parameters for diagnosing manifest glaucoma: a systematic review of diagnostic accuracy studies. Ophthalmology 123(5):939–949PubMedCrossRef
14.
Zurück zum Zitat Lingham G, Lee SS, Charng J, Clark A, Chen FK, Yazar S, Mackey DA (2021) Distribution and classification of peripapillary retinal nerve fiber layer thickness in healthy young adults. Transl Vis Sci Technol 10(9):3PubMedPubMedCentralCrossRef Lingham G, Lee SS, Charng J, Clark A, Chen FK, Yazar S, Mackey DA (2021) Distribution and classification of peripapillary retinal nerve fiber layer thickness in healthy young adults. Transl Vis Sci Technol 10(9):3PubMedPubMedCentralCrossRef
15.
16.
Zurück zum Zitat Tick S, Rossant F, Ghorbel I, Gaudric A, Sahel JA, Chaumet-Riffaud P, Paques M (2011) Foveal shape and structure in a normal population. Invest Ophthalmol Vis Sci 52(8):5105–5110PubMedCrossRef Tick S, Rossant F, Ghorbel I, Gaudric A, Sahel JA, Chaumet-Riffaud P, Paques M (2011) Foveal shape and structure in a normal population. Invest Ophthalmol Vis Sci 52(8):5105–5110PubMedCrossRef
17.
Zurück zum Zitat Samani NN, Proudlock FA, Siram V, Suraweera C, Hutchinson C, Nelson CP, Al-Uzri M, Gottlob I (2018) Retinal layer abnormalities as biomarkers of schizophrenia. Schizophr Bull 44(4):876–885PubMedCrossRef Samani NN, Proudlock FA, Siram V, Suraweera C, Hutchinson C, Nelson CP, Al-Uzri M, Gottlob I (2018) Retinal layer abnormalities as biomarkers of schizophrenia. Schizophr Bull 44(4):876–885PubMedCrossRef
18.
Zurück zum Zitat Demmin DL, Davis Q, Roche M, Silverstein SM (2018) Electroretinographic anomalies in schizophrenia. J Abnorm Psychol 127(4):417–428PubMedCrossRef Demmin DL, Davis Q, Roche M, Silverstein SM (2018) Electroretinographic anomalies in schizophrenia. J Abnorm Psychol 127(4):417–428PubMedCrossRef
19.
Zurück zum Zitat Pilat AV, Proudlock FA, Mohammad S, Gottlob I (2014) Normal macular structure measured with optical coherence tomography across ethnicity. Br J Ophthalmol 98(7):941–945PubMedCrossRef Pilat AV, Proudlock FA, Mohammad S, Gottlob I (2014) Normal macular structure measured with optical coherence tomography across ethnicity. Br J Ophthalmol 98(7):941–945PubMedCrossRef
20.
Zurück zum Zitat Ctori I, Huntjens B (2017) The association between foveal morphology and macular pigment spatial distribution: an ethnicity study. PLoS ONE 12(1):e0169520PubMedPubMedCentralCrossRef Ctori I, Huntjens B (2017) The association between foveal morphology and macular pigment spatial distribution: an ethnicity study. PLoS ONE 12(1):e0169520PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Bozali E, Yalinbas D (2022) Analysis of the thickness of the outer retinal layer using optical coherence tomography—a predictor of visual acuity in schizophrenia. Klin Monbl Augenheilkd 239(10):1232–1238PubMedCrossRef Bozali E, Yalinbas D (2022) Analysis of the thickness of the outer retinal layer using optical coherence tomography—a predictor of visual acuity in schizophrenia. Klin Monbl Augenheilkd 239(10):1232–1238PubMedCrossRef
22.
Zurück zum Zitat Phillips MR, Xiong W, Wang RW, Gao YH, Wang XQ, Zhang NP (1991) Reliability and validity of the chinese versions of the scales for assessment of positive and negative symptoms. Acta Psychiat Scand 84(4):364–370PubMedCrossRef Phillips MR, Xiong W, Wang RW, Gao YH, Wang XQ, Zhang NP (1991) Reliability and validity of the chinese versions of the scales for assessment of positive and negative symptoms. Acta Psychiat Scand 84(4):364–370PubMedCrossRef
23.
Zurück zum Zitat Leucht S, Crippa A, Siafis S, Patel MX, Orsini N, Davis JM (2020) Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia. Am J Psychiatry 177(4):342–353PubMedCrossRef Leucht S, Crippa A, Siafis S, Patel MX, Orsini N, Davis JM (2020) Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia. Am J Psychiatry 177(4):342–353PubMedCrossRef
24.
Zurück zum Zitat Song Y, Tham YC, Chong C, Ong R, Fenner BJ, Cheong KX, Takahashi K, Jordan-Yu JM, Teo KYC, Tan ACS et al (2021) Patterns and determinants of choroidal thickness in a multiethnic Asian population: the singapore epidemiology of eye diseases study. Ophthalmol Retina 5(5):458–467PubMedCrossRef Song Y, Tham YC, Chong C, Ong R, Fenner BJ, Cheong KX, Takahashi K, Jordan-Yu JM, Teo KYC, Tan ACS et al (2021) Patterns and determinants of choroidal thickness in a multiethnic Asian population: the singapore epidemiology of eye diseases study. Ophthalmol Retina 5(5):458–467PubMedCrossRef
25.
Zurück zum Zitat Asanad S, O’Neill H, Addis H, Chen S, Wang J, Goldwaser E, Kochunov P, Hong LE, Saeedi OJ (2021) Neuroretinal biomarkers for schizophrenia spectrum disorders. Transl Vis Sci Technol 10(4):29PubMedPubMedCentralCrossRef Asanad S, O’Neill H, Addis H, Chen S, Wang J, Goldwaser E, Kochunov P, Hong LE, Saeedi OJ (2021) Neuroretinal biomarkers for schizophrenia spectrum disorders. Transl Vis Sci Technol 10(4):29PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Bannai D, Lizano P, Kasetty M, Lutz O, Zeng V, Sarvode S, Kim LA, Hill S, Tamminga C, Clementz B et al (2020) Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: a preliminary study. Psychiatry Res Neuroimaging 299:111061PubMedPubMedCentralCrossRef Bannai D, Lizano P, Kasetty M, Lutz O, Zeng V, Sarvode S, Kim LA, Hill S, Tamminga C, Clementz B et al (2020) Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: a preliminary study. Psychiatry Res Neuroimaging 299:111061PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Friedel EBN, Hahn HT, Maier S, Kuchlin S, Reich M, Runge K, Bach M, Heinrich SP, Kornmeier J, Endres D et al (2022) Structural and functional retinal alterations in patients with paranoid schizophrenia. Transl Psychiatry 12(1):402PubMedPubMedCentralCrossRef Friedel EBN, Hahn HT, Maier S, Kuchlin S, Reich M, Runge K, Bach M, Heinrich SP, Kornmeier J, Endres D et al (2022) Structural and functional retinal alterations in patients with paranoid schizophrenia. Transl Psychiatry 12(1):402PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Schonfeldt-Lecuona C, Kregel T, Schmidt A, Kassubek J, Dreyhaupt J, Freudenmann RW, Connemann BJ, Gahr M, Pinkhardt EH (2020) Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder. Schizophr Res 219:5–12PubMedCrossRef Schonfeldt-Lecuona C, Kregel T, Schmidt A, Kassubek J, Dreyhaupt J, Freudenmann RW, Connemann BJ, Gahr M, Pinkhardt EH (2020) Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder. Schizophr Res 219:5–12PubMedCrossRef
29.
Zurück zum Zitat Komatsu H, Onoguchi G, Silverstein SM, Jerotic S, Sakuma A, Kanahara N, Kakuto Y, Ono T, Yabana T, Nakazawa T et al (2024) Retina as a potential biomarker in schizophrenia spectrum disorders: a systematic review and meta-analysis of optical coherence tomography and electroretinography. Mol Psychiatry 29(2):464–482PubMedCrossRef Komatsu H, Onoguchi G, Silverstein SM, Jerotic S, Sakuma A, Kanahara N, Kakuto Y, Ono T, Yabana T, Nakazawa T et al (2024) Retina as a potential biomarker in schizophrenia spectrum disorders: a systematic review and meta-analysis of optical coherence tomography and electroretinography. Mol Psychiatry 29(2):464–482PubMedCrossRef
30.
Zurück zum Zitat Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M, Li S, McCulloch DL (2022) ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144(3):165–177PubMedPubMedCentralCrossRef Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M, Li S, McCulloch DL (2022) ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144(3):165–177PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Hebert M, Merette C, Gagne AM, Paccalet T, Moreau I, Lavoie J, Maziade M (2020) The electroretinogram may differentiate schizophrenia from bipolar disorder. Biol Psychiatry 87(3):263–270PubMedCrossRef Hebert M, Merette C, Gagne AM, Paccalet T, Moreau I, Lavoie J, Maziade M (2020) The electroretinogram may differentiate schizophrenia from bipolar disorder. Biol Psychiatry 87(3):263–270PubMedCrossRef
32.
Zurück zum Zitat Holopigian K, Clewner L, Seiple W, Kupersmith MJ (1994) The effects of dopamine blockade on the human flash electroretinogram. Doc Ophthalmol 86(1):1–10PubMedCrossRef Holopigian K, Clewner L, Seiple W, Kupersmith MJ (1994) The effects of dopamine blockade on the human flash electroretinogram. Doc Ophthalmol 86(1):1–10PubMedCrossRef
33.
Zurück zum Zitat Bartel P, Blom M, Robinson E, Van der Meyden C, Sommers DO, Becker P (1990) Effects of chlorpromazine on pattern and flash ERGs and VEPs compared to oxazepam and to placebo in normal subjects. Electroencephalogr Clin Neurophysiol 77(5):330–339PubMedCrossRef Bartel P, Blom M, Robinson E, Van der Meyden C, Sommers DO, Becker P (1990) Effects of chlorpromazine on pattern and flash ERGs and VEPs compared to oxazepam and to placebo in normal subjects. Electroencephalogr Clin Neurophysiol 77(5):330–339PubMedCrossRef
34.
Zurück zum Zitat Bartel P, Blom M, Robinson E, van der Meyden C, Sommers DK, Becker P (1990) The effects of levodopa and haloperidol on flash and pattern ERGs and VEPs in normal humans. Doc Ophthalmol 76(1):55–64PubMedCrossRef Bartel P, Blom M, Robinson E, van der Meyden C, Sommers DK, Becker P (1990) The effects of levodopa and haloperidol on flash and pattern ERGs and VEPs in normal humans. Doc Ophthalmol 76(1):55–64PubMedCrossRef
35.
Zurück zum Zitat Mizota A, Adachi-Usami E (1993) Electroretinographic effects of haloperidol on the mouse retina. Doc Ophthalmol 85(2):151–160PubMedCrossRef Mizota A, Adachi-Usami E (1993) Electroretinographic effects of haloperidol on the mouse retina. Doc Ophthalmol 85(2):151–160PubMedCrossRef
36.
Zurück zum Zitat Dearry A, Falardeau P, Shores C, Caron MG (1991) D2 dopamine receptors in the human retina: cloning of cDNA and localization of mRNA. Cell Mol Neurobiol 11(5):437–453PubMedCrossRef Dearry A, Falardeau P, Shores C, Caron MG (1991) D2 dopamine receptors in the human retina: cloning of cDNA and localization of mRNA. Cell Mol Neurobiol 11(5):437–453PubMedCrossRef
37.
Zurück zum Zitat Stone J, Maslim J, Valter-Kocsi K, Mervin K, Bowers F, Chu Y, Barnett N, Provis J, Lewis G, Fisher SK et al (1999) Mechanisms of photoreceptor death and survival in mammalian retina. Prog Retin Eye Res 18(6):689–735PubMedCrossRef Stone J, Maslim J, Valter-Kocsi K, Mervin K, Bowers F, Chu Y, Barnett N, Provis J, Lewis G, Fisher SK et al (1999) Mechanisms of photoreceptor death and survival in mammalian retina. Prog Retin Eye Res 18(6):689–735PubMedCrossRef
38.
Zurück zum Zitat Tong JY, Pai A, Heydon P, Young SH (2017) Clozapine-induced maculopathy. Med J Aust 206(6):246PubMedCrossRef Tong JY, Pai A, Heydon P, Young SH (2017) Clozapine-induced maculopathy. Med J Aust 206(6):246PubMedCrossRef
39.
Zurück zum Zitat Faure C, Audo I, Zeitz C, Letessier JB, Robert MP (2015) Aripiprazole-induced chorioretinopathy: multimodal imaging and electrophysiological features. Doc Ophthalmol 131(1):35–41PubMedCrossRef Faure C, Audo I, Zeitz C, Letessier JB, Robert MP (2015) Aripiprazole-induced chorioretinopathy: multimodal imaging and electrophysiological features. Doc Ophthalmol 131(1):35–41PubMedCrossRef
40.
Zurück zum Zitat Scholz RT Sr, Sunness JS (2014) Dark adaptation abnormalities and recovery in acute thioridazine toxicity. Retin Cases Brief Rep 8(1):45–49PubMedCrossRef Scholz RT Sr, Sunness JS (2014) Dark adaptation abnormalities and recovery in acute thioridazine toxicity. Retin Cases Brief Rep 8(1):45–49PubMedCrossRef
41.
Zurück zum Zitat Filip V, Balik J (1978) Possible indication of dopaminergic blockade in man by electroretinography. Int Pharmacopsychiatry 13(3):151–156PubMedCrossRef Filip V, Balik J (1978) Possible indication of dopaminergic blockade in man by electroretinography. Int Pharmacopsychiatry 13(3):151–156PubMedCrossRef
42.
Zurück zum Zitat Miyata M, Imai H, Ishikawa S, Nakajima S (1980) Change in human electroretinography associated with thioridazine administration. Ophthalmologica 181(3–4):175–180PubMedCrossRef Miyata M, Imai H, Ishikawa S, Nakajima S (1980) Change in human electroretinography associated with thioridazine administration. Ophthalmologica 181(3–4):175–180PubMedCrossRef
43.
Zurück zum Zitat Kreis J, Carroll J (2024) Applications of adaptive optics imaging for studying conditions affecting the fovea. Annu Rev Vis Sci 10:239CrossRef Kreis J, Carroll J (2024) Applications of adaptive optics imaging for studying conditions affecting the fovea. Annu Rev Vis Sci 10:239CrossRef
44.
Zurück zum Zitat Silverstein SM, Paterno D, Cherneski L, Green S (2018) Optical coherence tomography indices of structural retinal pathology in schizophrenia. Psychol Med 48(12):2023–2033PubMedCrossRef Silverstein SM, Paterno D, Cherneski L, Green S (2018) Optical coherence tomography indices of structural retinal pathology in schizophrenia. Psychol Med 48(12):2023–2033PubMedCrossRef
45.
Zurück zum Zitat Jerotic S, Ristic I, Pejovic S, Mihaljevic M, Pavlovic Z, Britvic D, Ignjatovic Z, Silverstein SM, Maric NP (2020) Retinal structural abnormalities in young adults with psychosis spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 98:109825PubMedCrossRef Jerotic S, Ristic I, Pejovic S, Mihaljevic M, Pavlovic Z, Britvic D, Ignjatovic Z, Silverstein SM, Maric NP (2020) Retinal structural abnormalities in young adults with psychosis spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 98:109825PubMedCrossRef
46.
Zurück zum Zitat Sheehan N, Bannai D, Silverstein SM, Lizano P (2024) Neuroretinal alterations in schizophrenia and bipolar disorder: an updated meta-analysis. Schizophr Bull 50:1067PubMedCrossRef Sheehan N, Bannai D, Silverstein SM, Lizano P (2024) Neuroretinal alterations in schizophrenia and bipolar disorder: an updated meta-analysis. Schizophr Bull 50:1067PubMedCrossRef
47.
Zurück zum Zitat Lizano P, Bannai D, Lutz O, Kim LA, Miller J, Keshavan M (2020) A meta-analysis of retinal cytoarchitectural abnormalities in schizophrenia and bipolar disorder. Schizophr Bull 46(1):43–53PubMedCrossRef Lizano P, Bannai D, Lutz O, Kim LA, Miller J, Keshavan M (2020) A meta-analysis of retinal cytoarchitectural abnormalities in schizophrenia and bipolar disorder. Schizophr Bull 46(1):43–53PubMedCrossRef
48.
Zurück zum Zitat Pan J, Zhou Y, Xiang Y, Yu J (2018) Retinal nerve fiber layer thickness changes in Schizophrenia: a meta-analysis of case-control studies. Psychiatry Res 270:786–791PubMedCrossRef Pan J, Zhou Y, Xiang Y, Yu J (2018) Retinal nerve fiber layer thickness changes in Schizophrenia: a meta-analysis of case-control studies. Psychiatry Res 270:786–791PubMedCrossRef
49.
Zurück zum Zitat Shew W, Zhang DJ, Menkes DB, Danesh-Meyer HV (2024) Optical coherence tomography in schizophrenia spectrum disorders: a systematic review and meta-analysis. Biol Psychiatry Glob Open Sci 4(1):19–30PubMedCrossRef Shew W, Zhang DJ, Menkes DB, Danesh-Meyer HV (2024) Optical coherence tomography in schizophrenia spectrum disorders: a systematic review and meta-analysis. Biol Psychiatry Glob Open Sci 4(1):19–30PubMedCrossRef
50.
Zurück zum Zitat Kazakos CT, Karageorgiou V (2020) Retinal changes in schizophrenia: a systematic review and meta-analysis based on individual participant data. Schizophr Bull 46(1):27–42PubMed Kazakos CT, Karageorgiou V (2020) Retinal changes in schizophrenia: a systematic review and meta-analysis based on individual participant data. Schizophr Bull 46(1):27–42PubMed
51.
Zurück zum Zitat Schonfeldt-Lecuona C, Kregel T, Schmidt A, Pinkhardt EH, Lauda F, Kassubek J, Connemann BJ, Freudenmann RW, Gahr M (2016) From imaging the brain to imaging the retina: optical coherence tomography (OCT) in schizophrenia. Schizophr Bull 42(1):9–14PubMed Schonfeldt-Lecuona C, Kregel T, Schmidt A, Pinkhardt EH, Lauda F, Kassubek J, Connemann BJ, Freudenmann RW, Gahr M (2016) From imaging the brain to imaging the retina: optical coherence tomography (OCT) in schizophrenia. Schizophr Bull 42(1):9–14PubMed
52.
Zurück zum Zitat Christinaki E, Kulenovic H, Hadoux X, Baldassini N, Van Eijgen J, De Groef L, Stalmans I, van Wijngaarden P (2022) Retinal imaging biomarkers of neurodegenerative diseases. Clin Exp Optom 105(2):194–204PubMedCrossRef Christinaki E, Kulenovic H, Hadoux X, Baldassini N, Van Eijgen J, De Groef L, Stalmans I, van Wijngaarden P (2022) Retinal imaging biomarkers of neurodegenerative diseases. Clin Exp Optom 105(2):194–204PubMedCrossRef
53.
Zurück zum Zitat Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ (2012) Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 36(4):1342–1356PubMedCrossRef Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ (2012) Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 36(4):1342–1356PubMedCrossRef
54.
Zurück zum Zitat Kahn RS, Keefe RS (2013) Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiat 70(10):1107–1112CrossRef Kahn RS, Keefe RS (2013) Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiat 70(10):1107–1112CrossRef
55.
Zurück zum Zitat Liu Y, Huang L, Tong Y, Chen J, Gao D, Yang F (2020) Association of retinal nerve fiber abnormalities with serum CNTF and cognitive functions in schizophrenia patients. PeerJ 8:e9279PubMedPubMedCentralCrossRef Liu Y, Huang L, Tong Y, Chen J, Gao D, Yang F (2020) Association of retinal nerve fiber abnormalities with serum CNTF and cognitive functions in schizophrenia patients. PeerJ 8:e9279PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Boudriot E, Schworm B, Slapakova L, Hanken K, Jager I, Stephan M, Gabriel V, Ioannou G, Melcher J, Hasanaj G et al (2023) Optical coherence tomography reveals retinal thinning in schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci 273(3):575–588PubMedCrossRef Boudriot E, Schworm B, Slapakova L, Hanken K, Jager I, Stephan M, Gabriel V, Ioannou G, Melcher J, Hasanaj G et al (2023) Optical coherence tomography reveals retinal thinning in schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci 273(3):575–588PubMedCrossRef
57.
Zurück zum Zitat von Hanno T, Hareide LL, Smabrekke L, Morseth B, Sneve M, Erke MG, Mathiesen EB, Bertelsen G (2022) Macular layer thickness and effect of BMI, body fat, and traditional cardiovascular risk factors: the Tromso study. Invest Ophthalmol Vis Sci 63(9):16CrossRef von Hanno T, Hareide LL, Smabrekke L, Morseth B, Sneve M, Erke MG, Mathiesen EB, Bertelsen G (2022) Macular layer thickness and effect of BMI, body fat, and traditional cardiovascular risk factors: the Tromso study. Invest Ophthalmol Vis Sci 63(9):16CrossRef
58.
Zurück zum Zitat Blose BA, Lai A, Crosta C, Thompson JL, Silverstein SM (2023) Retinal neurodegeneration as a potential biomarker of accelerated aging in schizophrenia spectrum disorders. Schizophr Bull 59:1316CrossRef Blose BA, Lai A, Crosta C, Thompson JL, Silverstein SM (2023) Retinal neurodegeneration as a potential biomarker of accelerated aging in schizophrenia spectrum disorders. Schizophr Bull 59:1316CrossRef
59.
Zurück zum Zitat Tasdelen R, Ayik B, Kaya H, Sevimli N (2023) Investigation of the relationship between cognitive functions and retinal findings from spectral optical coherence tomography in patients with schizophrenia and their healthy siblings. Psychiatry Investig 20(3):236–244PubMedPubMedCentralCrossRef Tasdelen R, Ayik B, Kaya H, Sevimli N (2023) Investigation of the relationship between cognitive functions and retinal findings from spectral optical coherence tomography in patients with schizophrenia and their healthy siblings. Psychiatry Investig 20(3):236–244PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Zhuo C, Xiao B, Ji F, Lin X, Jiang D, Tian H, Xu Y, Wang W, Chen C (2021) Patients with first-episode untreated schizophrenia who experience concomitant visual disturbances and auditory hallucinations exhibit co-impairment of the brain and retinas-a pilot study. Brain Imaging Behav 15(3):1533–1541PubMedCrossRef Zhuo C, Xiao B, Ji F, Lin X, Jiang D, Tian H, Xu Y, Wang W, Chen C (2021) Patients with first-episode untreated schizophrenia who experience concomitant visual disturbances and auditory hallucinations exhibit co-impairment of the brain and retinas-a pilot study. Brain Imaging Behav 15(3):1533–1541PubMedCrossRef
61.
Zurück zum Zitat Altun IK, Turedi N, Aras N, Atagun MI (2020) Psychopharmacological signatures in the retina in schizophrenia and bipolar disorder: an optic coherence tomography study. Psychiatr Danub 32(3–4):351–358PubMedCrossRef Altun IK, Turedi N, Aras N, Atagun MI (2020) Psychopharmacological signatures in the retina in schizophrenia and bipolar disorder: an optic coherence tomography study. Psychiatr Danub 32(3–4):351–358PubMedCrossRef
62.
Zurück zum Zitat Xiao Q, Li F, Jiang F, Zhang Z, Xu B (2024) The prospects for early detection with optical coherence tomography (OCT) and OCT angiography in major depressive disorder. J Affect Disord 347:8–14PubMedCrossRef Xiao Q, Li F, Jiang F, Zhang Z, Xu B (2024) The prospects for early detection with optical coherence tomography (OCT) and OCT angiography in major depressive disorder. J Affect Disord 347:8–14PubMedCrossRef
Metadaten
Titel
Thinning of central foveal thickness in the retina of patients with schizophrenia
verfasst von
Jiayi Zhu
Zijing Wang
Tianzhen Chen
Yun Zhou
Feikang Xu
Jiang Du
Min Zhao
Publikationsdatum
08.12.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-024-01943-4

Neu im Fachgebiet Psychiatrie

Einer von sieben Frauen macht die Menopause sehr zu schaffen

Von mäßigen bis schweren vasomotorischen Beschwerden sind 14,7% der Frauen in der Postmenopause betroffen. Das haben kanadische Forscherinnen in einer Subgruppenanalyse der WARM-Studie herausgefunden.

Depressive Senioren fahren besonders riskant

Beim Autofahren machen ältere Depressive häufiger eine Vollbremsung, gehen öfter zu schnell in Kurven und halten sich seltener an Tempolimits als Senioren ohne Depression. Offenbar scheint eine Depression eine riskante Fahrweise im Alter zu verstärken.

Verhaltenstherapie plus Stimulanz reduziert Binge Eating

Die Kombination von kognitiver Verhaltenstherapie plus Lisdexamfetamin bringt Personen mit Binge-Eating-Störung deutlich häufiger in Remission als die jeweiligen Einzeltherapien. Zudem nimmt das Gewicht der Betroffenen spürbar ab.

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.